Valuation: Circio Holding ASA

Market Cap 2.01B 211M 183M 170M 157M 295M 20.13B 301M 2.01B 788M 10B 792M 775M 33.62B P/E 2024
0.25x
P/E 2025 -2.65x
Enterprise Value 2.02B 211M 183M 170M 157M 296M 20.15B 301M 2.02B 789M 10.01B 793M 775M 33.66B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
86.36%
Yield 2024 *
-
Yield 2025 -

Last Transcript: Circio Holding ASA

1 day-2.20%
1 week-4.94%
Current month+14.79%
1 month+14.79%
3 months-10.10%
6 months+633.10%
Current year+626.80%
1 week 8.34
Extreme 8.34
9.5
1 month 7.12
Extreme 7.12
9.5
Current year 0.98
Extreme 0.978
14.46
1 year 0.55
Extreme 0.547
14.46
3 years 0.48
Extreme 0.48
19.62
5 years 0.48
Extreme 0.48
236.7
10 years 0.48
Extreme 0.48
1,017
Manager TitleAgeSince
Chief Executive Officer - 20/10/2021
Director of Finance/CFO 58 07/03/2022
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Director/Board Member 79 01/07/2015
Director/Board Member 66 14/09/2015
Chairman 64 29/04/2020
Date Insider Type Main position Quantity % Market Cap.
11/30/21 A Fiscal year

Chief Executive Officer

120,000 0.1386%
5/19/21 A Buy

Director

21,299 0.0246%
12/3/20 A Buy

Chief Technology Officer

10,000 0.0116%
Change 5-day change 1-year change 3-year change Capi.($)
-2.20%-4.94%+1,282.35%-50.79% 213M
-0.81%-0.33%+27.15%+81.12% 55.6B
-3.74%-6.32%+42.70%+64.45% 55.2B
-0.11%+0.86%-15.63%-13.56% 23.51B
-1.58%-5.51%-3.51%+375.36% 22.35B
+2.33%-1.07%+20.12%-12.29% 20.6B
-1.23%-3.15%+26.00%-31.88% 17.45B
+1.37%-5.14%+17.21%+545.40% 15.16B
+1.16%+0.58%+51.87%+181.96% 13.91B
-5.09%-10.87%+153.11%+272.20% 13.74B
Average -0.99%-1.51%+160.14%+141.20% 23.77B
Weighted average by Cap. -1.25%-0.46%+32.17%+125.60%

Financials

2024 2025
Net sales - -
Net income 57.52M 6.02M 5.23M 4.86M 4.48M 8.44M 575M 8.59M 57.51M 22.52M 286M 22.61M 22.12M 960M -45.91M -4.81M -4.17M -3.88M -3.58M -6.73M -459M -6.86M -45.89M -17.97M -228M -18.05M -17.65M -766M
Net Debt -972K -102K -88.39K -82.08K -75.7K -143K -9.71M -145K -972K -380K -4.82M -382K -374K -16.23M 2.24M 235K 204K 190K 175K 329K 22.44M 335K 2.24M 879K 11.14M 883K 863K 37.48M
Logo Circio Holding ASA
Circio Holding ASA, formerly Targovax ASA, is a Norway-based company active within the healthcare sector. The Company is engaged in the biotechnology and develops ribonucleic acid (RNA) and immunotherapy medicines. The Company offers circular RNA (circRNA) platform to develop circRNA medicines for cancer, vaccines, protein replacement for genetic disorders and cell therapy. The circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA-based vectors that can be deployed for multiple purposes. Circios strategy is to develop circAde cancer medicines in-house and seek partnerships in other therapeutic areas to demonstrate the broad potential of the circVec platform and accelerate circRNA pipeline development. Circio’s second clinical program is an immunotherapy targeting KRAS driver mutations.
Employees
10
Date Price Change Volume
30/07/26 NOK 8.460 -2.20% 2,942,912
29/07/26 NOK 8.650 -3.57% 3,294,210
28/07/26 NOK 8.970 -4.17% 5,079,477
27/07/26 NOK 9.360 +1.19% 5,941,579
24/07/26 NOK 9.250 +3.93% 6,181,045

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TRVX Stock